CRON - Cronos Group Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
21.41
-0.28 (-1.27%)
As of 11:26AM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close21.69
Open21.89
Bid21.40 x 800
Ask21.41 x 1400
Day's Range21.26 - 22.04
52 Week Range5.12 - 25.10
Volume3,487,209
Avg. Volume15,768,951
Market Cap3.842B
Beta (3Y Monthly)4.28
PE Ratio (TTM)N/A
EPS (TTM)-0.03
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • CNW Group3 hours ago

    Hemp Boom Leads to Cultivation Supply Shortages

    DENVER, March 19, 2019 /CNW/ -- The growth of the hemp sector is having a beneficial effect for both hemp companies and hydroponic suppliers. Sugarmade Inc. (OTC:SGMD - News) (SGMD Profile) via its pending acquisitions is poised to accelerate its growth rate as a result of this hemp cultivation boom, along with other leading companies. Tilray Inc. (NASDAQ:TLRY - News) has been expanding through the acquisition of other companies and a move into Europe, with a successful harvest in Portugal.

  • ACCESSWIRE3 hours ago

    Highlighting Rising Cannabis Companies

    HENDERSON, NV / ACCESSWIRE / March 19, 2019 / From a dirty little secret to one of the fastest growing industries in the world, cannabis has come a long way. As more states are legalizing medical marijuana ...

  • Is Cronos Group Stock Too Expensive to Buy?
    Motley Fool5 hours ago

    Is Cronos Group Stock Too Expensive to Buy?

    The analysts are down on Cronos. Should you be, too?

  • Cronos Group's $1.8 Billion Investment From Altria Has Closed. Now What?
    Motley Fool2 days ago

    Cronos Group's $1.8 Billion Investment From Altria Has Closed. Now What?

    Here's what Cronos Group should do with its new-found fortune.

  • Buy This, Not That: The Marijuana Stock Edition
    Motley Fool3 days ago

    Buy This, Not That: The Marijuana Stock Edition

    Popular pot stocks don't always make for the best investments.

  • CNW Group5 days ago

    Cannabis Reaches New Demographics Due to its Medical Appeal

    The statistics show that cannabis consumption has increased among the older generations since the previous survey in 2013 as almost a quarter of those over 65 were prescribed cannabis as a treatment from their doctors in 2016. While recreational cannabis laws are still regulated in most U.S. states and even internationally, medical cannabis regulations are much more lenient because of the plant's therapeutic effects. Now, consumers are using cannabis to treat medical conditions such as cancer, chronic pain, and arthritis.

  • 3 Top Marijuana Stocks to Watch in March
    Motley Fool5 days ago

    3 Top Marijuana Stocks to Watch in March

    Three of the biggest Canadian pot companies made the list.

  • Cronos Group (CRON) Stock Sinks As Market Gains: What You Should Know
    Zacks6 days ago

    Cronos Group (CRON) Stock Sinks As Market Gains: What You Should Know

    In the latest trading session, Cronos Group (CRON) closed at $21.14, marking a -1.08% move from the previous day.

  • CNW Group6 days ago

    Hemp CBD Infused Product Market Projected to Triple by 2022

    PALM BEACH, Florida, March 13, 2019 /CNW/ -- The passage of the U.S. Farm bill, which restored industrial hemp to nationwide legal production for the first time since World War II, has been generating a financial windfall for North American cannabis companies. A recent post from industry watchers on the net said: "More broadly, the passage of the Farm Bill represents a sweeping change in the balance of power in global hemp markets. The United States has historically been an importer of hemp products from Canada, Europe, and China.

  • ACCESSWIRE7 days ago

    Watch These Four Marijuana Stocks Surpass Investor Expectations on Tuesday

    In regards to the cannabis industry's recent bull run, the positive trends can be attributed to two key factors: legislative efforts and a general shift in public opinion. Recently, lawmakers have advocated for legislation in support of cannabis legislation, and this has given cannabis companies more societal credibility. Transcanna Holdings Inc (TCAN.CN), Aphria Inc (NYSE:APHA), Harvest Health & Recreation Inc (HARV.CN), and Cronos Group Inc (CRON) are four cannabis companies worth looking into.

  • CNW Group7 days ago

    Millennials, Generation X and Gen Z are all Unanimous in Their Position to Legalize Marijuana

    LOS ANGELES, March 12, 2019 /CNW/ -- It appears that there is strong consensus amongst major populations groups who will ultimately determine the viability of legal marijuana in the US. The news is further support for the development by a broad group of cannabis and CBD companies who are preparing for adoption with efforts to fill the new demand for marijuana, hemp and CBD products including Tilray, Inc. (NASDAQ:TLRY - News), Cronos Group (NASDAQ:CRON - News) (TSX:CRON.TO - News) and AmeriCann, Inc. (OTC:ACAN - News). As this trend takes hold, the CBD products sector is expected to grow at an equal pace.

  • Altria Focuses on RRPs Growth, Closes Investment in Cronos
    Zacks8 days ago

    Altria Focuses on RRPs Growth, Closes Investment in Cronos

    Altria (MO) closes investment deal in Cronos Group. The move is in sync with the company's efforts to expand in the smokeless category.

  • ACCESSWIRE8 days ago

    Addressing Cannabis' Energy Problem

    HENDERSON, NV / ACCESSWIRE / March 11, 2019 / From the beginning of the year (YTD) to March 9, 2019, the first tradable cannabis ETF, the Horizons Marijuana Life Sciences Index ETF, was up over 50%. Unfortunately, ...

  • GlobeNewswire11 days ago

    Cronos Group Inc. Closes C$2.4 Billion Strategic Growth Investment from Altria Group, Inc.

    Cronos Group Inc. (CRON.TO) (CRON.TO) (“Cronos Group” or the “Company”) today announced that the C$2.4 billion equity investment in the Company by Altria Group, Inc. (MO) (“Altria”) has closed. As previously announced, Altria’s investment represents an approximate 45% ownership interest in Cronos Group.

  • Business Wire11 days ago

    Altria Becomes Largest Shareholder in Cronos Group, a Leading Global Cannabinoid Company

    Altria’s investment represents an approximate 45% economic and voting interest in Cronos Group with a warrant to acquire additional ownership at a price of CAD $19.00 per share, exercisable over the next four years. If exercised in full today, the warrant would increase Altria’s ownership in Cronos Group to approximately 55%. Under the terms of the transaction, Altria nominated four directors who were recently elected to serve on Cronos Group’s seven member board: Kevin C. Crosthwaite, Jr., Murray R. Garnick, Bruce A. Gates and Bronwen Evans.

  • CNW Group12 days ago

    Latest Extraction Techniques Filling Consumer Demand For Wider Range of CBD Rich Concentrates

    PALM BEACH, Florida, March 7, 2019 /CNW/ -- In an article titled: "The Economics of Extraction" the Cannabis Business Times (CBT) predicted that consumers will demand more and more retail choices: "CBT reported that vape cartridge sales in California reached $100 million for the combined months of November and December 2017. The stated total of all concentrate revenue in California for that same period was $140.9 million Based on those figures, it's clear that vape cartridges dominate sales. The simple answer: user convenience." The article continued: "With this data, some companies will successfully focus strictly on cartridge sales, but the cartridge industry is destined to become competitive and saturated.

  • CRON, ACB, WEED, and APHA Bleed after a Run-Up Yesterday
    Market Realist13 days ago

    CRON, ACB, WEED, and APHA Bleed after a Run-Up Yesterday

    CRON, ACB, WEED, and APHA Bleed after a Run-Up YesterdayCannabis sector ETFs The cannabis sector ETFs were trading in the red in the first half of the day, with the Horizons Marijuana Life Sciences ETF (HMMJ) falling 1.7% and the ETFMG Alternative

  • Zacks13 days ago

    Stocks Get Stuck Waiting for Trade Deal

    Stocks Get Stuck Waiting for Trade Deal

  • Market Exclusive13 days ago

    Aurora Acquires Premium Cannabis Products Maker

    Aurora Cannabis (TSX: ACB) (NYSE: ACB) has announced that it has acquired privately-held Whistler Medical Marijuana in an all-share transaction. The company bought all issued and outstanding shares of Whistler under the terms of an agreement among Whistler, Aurora, and a wholly-owned subsidiary of Aurora. In a separate statement, Cronos Group (NASDAQ: CRON) (TSX: CRON) said […]The post Aurora Acquires Premium Cannabis Products Maker appeared first on Market Exclusive.

  • GlobeNewswire13 days ago

    Report: Exploring Fundamental Drivers Behind SunPower, Tyler Technologies, Cronos Group, Weight Watchers International, Meredith, and Gol Linhas Aereas Inteligentes S.A — New Horizons, Emerging Trends, and Upcoming Developments

    NEW YORK, March 06, 2019 -- In new independent research reports released early this morning, Capital Review released its latest key findings for all current investors, traders,.

  • Why Aphria’s Short Sellers Got Squeezed
    Market Realist14 days ago

    Why Aphria’s Short Sellers Got Squeezed

    Why Aphria Could Squeeze Out Short Sellers(Continued from Prior Part)Short sellers’ claims Aphria (APHA) received severe criticism from short sellers late last year over its acquisition in Latin America. Short sellers even rushed to call Aphria

  • ACCESSWIRE14 days ago

    Watch These Four Marijuana Stocks On Tuesday

    CORAL GABLES, FL / ACCESSWIRE / March 5, 2019 / The marijuana stock market has become the focal point of conversation over the course of the past few years, resulting in a bullish run for companies in the cannabis industry. Over that time period, countless new companies in the industry have gained notoriety for their innovative approaches to creating cannabis products for consumers. With the majority of U.S. states having some form of legal cannabis, either recreational or medicinal, the marijuana industry is whirring with excitement.

  • Cronos Group Got a ‘Market Perform’ Rating from Cowen
    Market Realist14 days ago

    Cronos Group Got a ‘Market Perform’ Rating from Cowen

    Cronos Group Got a ‘Market Perform’ Rating from Cowen“Market perform” for Cronos GroupOn March 5, Cowen initiated coverage on Cronos Group (CRON) with a “market perform” rating. Cowen also initiated coverage on Aurora Cannabis (ACB) with

  • Aurora Cannabis Got an ‘Outperform’ Rating from Cowen
    Market Realist14 days ago

    Aurora Cannabis Got an ‘Outperform’ Rating from Cowen

    Aurora Cannabis Got an ‘Outperform’ Rating from CowenCowen initiates coverage on Aurora Cannabis On March 5, Cowen initiated coverage on Aurora Cannabis (ACB) with an “outperform” rating. Cowen joins an increasing number of investment firms

  • GlobeNewswire15 days ago

    Cronos Group Inc. Exits Investment in Whistler Medical Marijuana Corporation

    Cronos Group Inc. (CRON.TO) (CRON.TO) (“Cronos Group” or the “Company”), confirmed today that it has sold all of its common shares in the capital of Whistler Medical Marijuana Corporation ("Whistler"), representing approximately 19 percent of Whistler’s issued and outstanding common shares, to Aurora Cannabis Inc. (“Aurora”) for a total purchase price of approximately C$175 million, payable by the issuance of common shares in the capital of Aurora (“Aurora Common Shares”), and subject to certain working capital adjustments and holdbacks (the “Transaction”).